MVE

Alif Semiconductor Announces World's First BLE and Matter Wireless Microcontroller to Feature Neural Co-Processor for AI/ML Workloads

Retrieved on: 
Tuesday, April 9, 2024
Cortex, Arm, LPA, BLE, Machine learning, Logic, LC3, Algorithm, DSP, HPA, WLCSP, Acceleration, Memory, Business, ARM Cortex-M, MCU, AI accelerator, Bluetooth Low Energy, Spacecraft, Senior, TWS, Architecture, Radio, DAC, NPU, TCM, GOPS, Family, MVE, Artificial intelligence, EEMBC, Lethargy, Video game

PLEASANTON, Calif., April 9, 2024 /PRNewswire/ -- Alif Semiconductor®, a leading global supplier of secure, connected, power efficient Artificial Intelligence and Machine Learning (AI/ML) microcontrollers (MCUs) and fusion processors, today announced the launch of the BallettoTM family, the world's first Bluetooth® Low Energy (BLE) wireless microcontroller to feature hardware optimization for AI/ML workloads.

Key Points: 
  • The Balletto family offers particularly strong performance in audio and sensor functions thanks to its excellent DSP and AI/ML capabilities and large on-die memory.
  • Neural network processing performance is up to 15x better than a Cortex-M4 processor can achieve.
  • Balletto includes the state-of-the-art multi-layered security fabric first introduced in Alif Semiconductors' Ensemble family of MCUs and fusion processors.
  • "Alif Semiconductor's Balletto family is targeting BLE challenges faced by the wireless audio and smart home industry today with a platform adapted to high bit-rate audio and the Matter ecosystem," said Reza Kazerounian, President and Co-Founder of Alif Semiconductor.

Alif Semiconductor Announces World's First BLE and Matter Wireless Microcontroller to Feature Neural Co-Processor for AI/ML Workloads

Retrieved on: 
Tuesday, April 9, 2024
Cortex, Arm, LPA, BLE, Machine learning, Logic, LC3, Algorithm, DSP, HPA, WLCSP, Acceleration, Memory, Business, ARM Cortex-M, MCU, AI accelerator, Bluetooth Low Energy, Spacecraft, Senior, TWS, Architecture, Radio, DAC, NPU, TCM, GOPS, Family, MVE, Artificial intelligence, EEMBC, Lethargy, Video game

PLEASANTON, Calif., April 9, 2024 /PRNewswire/ -- Alif Semiconductor®, a leading global supplier of secure, connected, power efficient Artificial Intelligence and Machine Learning (AI/ML) microcontrollers (MCUs) and fusion processors, today announced the launch of the BallettoTM family, the world's first Bluetooth® Low Energy (BLE) wireless microcontroller to feature hardware optimization for AI/ML workloads.

Key Points: 
  • The Balletto family offers particularly strong performance in audio and sensor functions thanks to its excellent DSP and AI/ML capabilities and large on-die memory.
  • Neural network processing performance is up to 15x better than a Cortex-M4 processor can achieve.
  • Balletto includes the state-of-the-art multi-layered security fabric first introduced in Alif Semiconductors' Ensemble family of MCUs and fusion processors.
  • "Alif Semiconductor's Balletto family is targeting BLE challenges faced by the wireless audio and smart home industry today with a platform adapted to high bit-rate audio and the Matter ecosystem," said Reza Kazerounian, President and Co-Founder of Alif Semiconductor.

MVE + Partners Announces the Opening of Its First Latin America Office in Guadalajara

Retrieved on: 
Monday, March 18, 2024
NCARB, Partner, WLI, INT, GDL, Aviation, United, Architecture, JAL, Senior, AIA, Creativity, FAIA, MVE, Drug

GUADALAJARA, Mexico, March 18, 2024 (GLOBE NEWSWIRE) -- MVE + Partners (MVE), a leading architecture, planning, interior design and urban design firm, today announced the opening of MVE Architects Mexico, its first Latin-America-based office in Guadalajara, Mexico.

Key Points: 
  • GUADALAJARA, Mexico, March 18, 2024 (GLOBE NEWSWIRE) -- MVE + Partners (MVE), a leading architecture, planning, interior design and urban design firm, today announced the opening of MVE Architects Mexico, its first Latin-America-based office in Guadalajara, Mexico.
  • Bernardis’ notable projects include Guadalajara International Airport’s Terminal 2 , Acuarela master plan , and Luna Luxury Residential Tower in San Pedro, Monterrey, as well as diverse projects in Latin America.
  • “I’m inspired by MVE’s body of work and honored to support the establishment of the first hub in Latin America.
  • Opening a Guadalajara location just felt like the natural next step,” said Matthew McLarand, AIA, NCARB, president, MVE.

Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, March 12, 2024
Risk, FY, Maas, Form, Blas, Gene, Animal Health, Reproductive medicine, Form 10-K, Security (finance), Marketing, Investment, Annual report, Debt-to-GDP ratio, Cell, Medicine, MVE, Pharmaceutical industry

Total revenue for Q4 2023 was $57.3 million compared to $60.4 million for Q4 2022, a year-over-year decrease of 5% or $3.1 million.

Key Points: 
  • Total revenue for Q4 2023 was $57.3 million compared to $60.4 million for Q4 2022, a year-over-year decrease of 5% or $3.1 million.
  • Biopharma/Pharma revenue was $47.9 million, down 5% or $2.7 million for Q4 2023 compared to $50.6 million for Q4 2022.
  • Animal Health revenue was $6.8 million for Q4 2023, down 10% or $0.7 million compared to $7.5 million for Q4 2022.
  • Reproductive Medicine revenue was $2.6 million for Q4 2023, up 11% compared to $2.3 million for Q4 2022.

CeraVe Collaborates with Michael Cera and TikTok Stars on First-of-its-Kind Global Campaign

Retrieved on: 
Monday, February 12, 2024
Super Bowl LVIII, Social media, Marketing, Cera, L'Oréal, Social marketing, SVP, News, Arrested Development, Super Bowl, Ceramide, Internet, Movement, Dermatology, DNA, MVE, Partnership, Cosmetics

NEW YORK, Feb. 12, 2024 /PRNewswire/ -- CeraVe, the #1 dermatologist-recommended skincare brand in the US, has revealed the epic conclusion to its inaugural Super Bowl ad in a first-of-its-kind campaign, developed in partnership with actor Michael Cera, viral dermatologists and TikTok's biggest stars.

Key Points: 
  • #1 Gen Z skincare brand in the U.S. goes big with hilarious campaign reinforcing CeraVe is developed with dermatologists not Michael Cera.
  • For weeks, Michael Cera has been front and center in the news and across social media promoting his 'namesake' brand, CeraVe.
  • In the days leading up to the big game, Cera went toe-to-toe with dermatologists and even revealed his very own Michael CeraVe commercial.
  • In fact, the "Ve" stands for MVE Technology and "Cera" refers to "ceramides," not Michael Cera.

CeraVe Collaborates with Michael Cera and TikTok Stars on First-of-its-Kind Global Campaign

Retrieved on: 
Monday, February 12, 2024
Social media, Marketing, Cera, L'Oréal, Social marketing, SVP, News, Arrested Development, Super Bowl, Ceramide, Movement, Dermatology, DNA, MVE, Partnership, Cosmetics

NEW YORK, Feb. 12, 2024 /PRNewswire/ -- CeraVe, the #1 dermatologist-recommended skincare brand in the US, has revealed the epic conclusion to its inaugural Super Bowl ad and first-of-its-kind global campaign, developed in partnership with actor Michael Cera, viral dermatologists and TikTok's biggest stars.

Key Points: 
  • #1 Gen Z skincare brand in the U.S. goes big with hilarious campaign reinforcing CeraVe is developed with dermatologists not Michael Cera.
  • For weeks, Michael Cera has been front and center in the news and across social media promoting his 'namesake' brand, CeraVe.
  • Cera went toe-to-toe with dermatologists and even revealed his very own Michael CeraVe commercial.
  • In fact, the "Ve" stands for MVE Technology and "Cera" refers to "ceramides," not Michael Cera.

Esperion Presents Results from New Analysis on Cardiovascular Benefits with Bempedoic Acid Treatment at ENDO 2023

Retrieved on: 
Thursday, June 15, 2023
ENDO, MVE, CV, Shoulder, Spasm, Fetus, Lactation, Pregnancy, Bempedoic acid, CTT, Pain, Patient, Analysis, Risk, Concentration ratio, The New England Journal of Medicine, Disease, Gout, Diet, Myocardial infarction, Ezetimibe, ANN, Drug, Simvastatin, Pravastatin, Back pain, ESPR, Tablet, Death, Safety, Rotator cuff, Atrial fibrillation, Stroke, CVD, Abdominal pain, Uric acid, Molina Healthcare, Anemia, Mortality, IL, Achilles tendon, Bronchitis, Tendon rupture, ATP, Rupture, Kidney, CLEAR, Moyamoya disease, Upper respiratory tract infection, Health, Pharmaceutical industry, Dietary supplement, Esperies, Hyperuricemia

“We are pleased to present this analysis at ENDO 2023, demonstrating that the cardiovascular risk reduction benefit of bempedoic acid treatment is comparable to that of statins based on an analysis of per unit decrease in LDL-C,” said Sheldon Koenig, President and CEO of Esperion.

Key Points: 
  • “We are pleased to present this analysis at ENDO 2023, demonstrating that the cardiovascular risk reduction benefit of bempedoic acid treatment is comparable to that of statins based on an analysis of per unit decrease in LDL-C,” said Sheldon Koenig, President and CEO of Esperion.
  • The beneficial effect of bempedoic acid on MVE reduction generally improved over time, similar to what was observed in statin CVOTs.
  • Limitations of Use: The effect of bempedoic acid on cardiovascular morbidity and mortality has not been determined.
  • CLEAR Outcomes is part of the CLEAR clinical research program for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet.

MVE + Partners Earns Two Top Honors at 2023 PCBC® Gold Nugget Awards

Retrieved on: 
Thursday, May 25, 2023
MVE, Gold Nugget, Partner, SHVO, Michelin, O'Connell Bridge House, Q factor, Privacy, PCBC, Gold, Restaurant, Grand Award Records, Architecture, Mandarin Oriental Hotel Group, Conference, Hotel, Film industry, Swinerton

MVE + Partners’ Mandarin Oriental Residences and Post District Residences projects were selected for the Gold Nugget top honors by a panel of top industry experts who reviewed nearly 650 entries.

Key Points: 
  • MVE + Partners’ Mandarin Oriental Residences and Post District Residences projects were selected for the Gold Nugget top honors by a panel of top industry experts who reviewed nearly 650 entries.
  • The Grand Award winners showcase the most exciting trends in design, planning and building across over 50 categories, including multifamily, affordable, mixed-use, and recreational facilities.
  • “As MVE and Partners approaches its 50th anniversary, this recognition inspires us to continue our dedication to innovative architectural design,” said Matthew McLarand, president and director of design, MVE + Partners.
  • “We share these awards with our partners SHVO, Bilgili Group, Deutsche Finance, Lowe Property Group, BCG Holdings, Q Factor, and Bridge Housing and thank them for trusting us to make their visions become reality.”
    This year’s Gold Nugget Grand Awards mark MVE + Partners’ 85th Grand Award over the past 47 years.

CeraVe Establishes Fund at Howard University to Address Lack of Diversity and Increase Representation of Skin of Color in Skincare Clinical Research

Retrieved on: 
Wednesday, November 16, 2022
Advertising, Technology, Pharmacy, Student, Research, Industry, National Institutes of Health, College, Skin, MVE, National, Schwarzman, Howard University, Leadership, Partnership, Howard University Hospital, University, Senior, Medicine, National Center for Research Resources, Department, Marketing, Clinical trial, Engineering, Historically black colleges and universities, Faculty, College of Medicine, S&E, L'Oréal, Population, Human services, School, African Americans, Multimedia, Certification, NIH, Color, Service, Science, Social media, NEW, Group, United States Department of Health and Human Services, Education, Thomas R. Pickering Foreign Affairs Fellowship, UIM, Employment, Contemporary Clinical Trials, Howard University College of Medicine, White, Cosmetics, Pharmaceutical industry, Hospital, Dermatology, Facebook, Black

NEW YORK, Nov. 16, 2022 /PRNewswire/ -- As a brand developed with dermatologists and backed by science, CeraVe is committed to providing safe and efficacious skincare products for all people and recognizes that there are representation gaps within the skincare industry. This includes representation at the clinical research level, both for participants of dermatological clinical trials and the investigators conducting them, of which there is a significant disparity for skin of color. To help close this existing racial inequity gap in dermatological research, CeraVe is establishing a fund at Howard University, one of the only historically Black universities with a Department of Dermatology, to help its faculty further their expertise and build the infrastructure needed to conduct clinical trials with a focus on skin of color.

Key Points: 
  • Diversity is not just lacking in those participating in clinical trials, but also in those conducting the trials.
  • The first stage of the partnership between CeraVe and Howard University, will help fund faculty education to obtain certification to conduct clinical trials.
  • By partnering with the Howard University Dermatology Department, CeraVe is helping the University become a leader in research and innovation of dermatological science for skin of color.
  • Both Howard University and CeraVe are committed to transform values into action to address the health inequities impacting people of color.

CeraVe Brings Some of Dermatology's Biggest Names and Social Media's Most Followed Skincare Enthusiasts Together to Teach Consumers How to #CleanseLikeaDerm

Retrieved on: 
Monday, August 1, 2022
Group, OnePoll, Beauty, View, Education, Skin, Research, Twitter, Instagram, Social media, Ageing, Pharmacy, Hyaluronic acid, L'Oréal, Multimedia, MVE, Technology, Communication, Dermatology, Cosmetics, TikTok, Facebook

NEW YORK, Aug. 1, 2022 /PRNewswire/ -- CeraVe, the #1 dermatologist recommended skincare brand in the United States1, is teaming up with board-certified dermatologists and two of the biggest dermatologist influencers on social media today – Dr. Dustin Portela (@208skindoc) and Dr. Michelle Henry (@drmichellehenry) – to host a global livestreamed event with skincare enthusiast and content creator Avani Gregg, who has amassed more than 41 million followers on TikTok (@avani). The event, which will stream live from New York City on August 2nd, marks the brand's first-ever global livestream in front of a live studio audience, as CeraVe will help consumers correct cleansing mistakes and establish healthier skincare habits.

Key Points: 
  • The event will underscore the benefits of gentle, yet effective cleansers like those from CeraVe.
  • That's why a CeraVe cleanser achieves a balance of efficiently removing debris, while being gentle on skin.
  • CeraVe has a full line of skincare products to follow the dermatologist-recommended steps of: cleanse, treat, moisturize, and protect.
  • L'Oral's sustainability commitment for 2020 "Sharing Beauty with All" sets out ambitious sustainable development objectives across the Group's value chain.